Exploring how N-ras and K-ras oncogene mutations differentially affect myeloma cell growth and treatment resistance in the ANBL6 cell line.
Exploring insulin's surprising dual role in cancer biology - acting as a growth factor for multiple myeloma while leaving similar cells unaffected.